Men who have sex with men (MSM) are the only key population in the countries of the European Union and European Economic Area that has not seen a decline in new HIV infections during the last decade.
The results of two clinical studies, PROUD and IPERGAY, suggests that the use of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) is an effective HIV prevention tool for Europe.
ECDC releases today an update of its tick-borne diseases communication toolkit to support public health authorities in devising communication initiatives as part of their tick-borne diseases prevention programmes.
The information sheet is mainly intended for people living in endemic areas who have been bitten by (a) tick(s) so as to inform them primarily about the symptoms that they have to be aware of.(Adaptable templates available)
On the occasion of World AIDS Day, ECDC launched the latest surveillance data on HIV in the European Region. 2014 theme: 10 years of data show that Europe is not curbing the epidemic
The use of pre-exposure prophylaxis (PrEP) as an HIV prevention strategy, particularly among men who have sex with men (MSM) as well as other population groups at higher risk of HIV infection, has been receiving more and more attention during 2014. Preliminary results of clinical trials and research studies suggest that it could be an effective HIV prevention tool for Europe.
From 21 to 28 November 2014, nearly 700 organisations across Europe will host activities to increase awareness of the personal and public health benefits of HIV testing. As HIV infection can remain asymptomatic for a long time and a substantial number of infected persons across Europe are unaware of their infection, ECDC supports the aims of this second European HIV testing week.
The U.S. Centers for Disease Control and Prevention published clinical practice guidelines on pre-exposure prophylaxis (PrEP) for the prevention of HIV. In EU, most countries lack implementation data and formal licensure and guidelines.
2014, the focus of World Health day was on vector-borne diseases. World Health Day is a worldwide initiative celebrated every year on 7 April to mark the anniversary of the founding of the World Health Organization (WHO) in 1948.
Monitoring and responding to HIV and hepatitis C among people who inject drugs is the focus of two new reports from the EU drugs agencies EMCDDA and ECDC.